Hydroxychloroquine Market Size, Share & Industry Analysis, By Disease Indication (Malaria, COVID-19, Rheumatoid Arthritis, Others), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Stores), and Regional Forecast, 2020-2027 (Includes COVID-19 Business Impact)

                                          
We have updated Hydroxychloroquine Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Hydroxychloroquine market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Hydroxychloroquine market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Hydroxychloroquine Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Hydroxychloroquine Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Hydroxychloroquine Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Acquisition of Johnson & Johnson Customers to Provide Leading Position to Medtronic
In terms of revenue, companies such as Sanofi, Sandoz International GmbH, and Zydus Cadila cumulatively accounted for the dominant share in the market. However, owing to the increase in the cases of Coronavirus infections around the globe these major manufacturers have increased the production capacities in their respective manufacturing facilities. India is a major manufacturer of hydroxychloroquine in the globe and accounts for 70% of the total demand volume of the market. Other players in the market include Ipca Laboratories Ltd, Mylan and Teva Pharmaceuticals Bayer AG.

LIST OF KEY COMPANIES PROFILED:

  
Sanofi
  
Zydus Cadila
  
Ipca Laboratories Ltd
  
Sandoz International GmbH (part of Novartis AG)
  
Mylan N.V.
  
Teva Pharmaceutical Industries Ltd
  
Bayer AG
  
Others

KEY INDUSTRY DEVELOPMENTS:

March 2020 -Novartis AG through its subsidiary Sandoz International GmbH announced that the company has committed to donate an estimated 130 Mn doses of hydroxychloroquine for the treatment of COVID-19

March 2020 -Teva Pharmaceutical Industries Limited announced that the company will donate hydroxychloroquine tablets to hospitals in the U.S. for the control and management of COVID-19 among affected population.

REPORT COVERAGE

The hydroxychloroquine market report offers an elaborative analysis of numerous factors affecting the market. These include opportunities, growth drivers, threats, key developments, and restraints. In addition to this, the report further helps in analyzing, segmenting, and defining the market based on different segments such as product type, disease indication and distribution channel. It strategically analyzes several strategies such as impact of COVID-19 outbreak, epidemiology of malaria, key development in this market, among others.

Report Scope & Segmentation

 Segmentation

By Disease Indications

  
Malaria
  
COVID-19
  
Rheumatoid Arthritis
  
Others

By Distribution Channel

  
Hospital Pharmacy
  
Retail Pharmacy
  
Online Stores

By Geography

  
North America (the U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
  
Latin America (Brazil, Mexico, and Rest of Latin America)
  
Middle East& Africa (South Africa, GCC and Rest of Middle East & Africa)